Harvard Bioscience Ownership | Who Owns Harvard Bioscience?

Overview Forecast RevenueFinancials Chart Transcripts

Harvard Bioscience Ownership Summary

Harvard Bioscience is owned by 8.43% institutional investors, 8.27% insiders, and 83.31% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 6.84% of HBIO shares. Harvey Partners Small-Cap Opportunity is the top mutual fund, with 4.58% of its assets in Harvard Bioscience shares.

HBIO Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Harvard Bioscience	8.43%	8.27%	83.31%
Sector	Healthcare Stocks	79.82%	9.81%	10.37%
Industry	Medical Instruments & Supplies Stocks	44.25%	12.59%	43.16%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	2.98M	6.84%	$6.29M
Blackrock	2.84M	6.55%	$8.10M
Punch & associates investment management	2.77M	6.39%	$7.90M
Amh equity	2.50M	5.73%	$5.28M
Harvey partners	2.19M	4.96%	$1.24M
Vanguard group	2.16M	4.95%	$4.55M
Royce & associates lp	1.97M	4.51%	$4.15M
Dimensional fund advisors lp	1.67M	3.82%	$3.51M
Granahan investment management	1.53M	3.46%	$864.79K
Heartland advisors	1.20M	2.75%	$2.53M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Amh equity	2.50M	5.19%	$5.28M
Acuitas investments	491.09K	0.85%	$1.04M
Meros investment management, lp	813.71K	0.77%	$1.72M
Punch & associates investment management	2.77M	0.46%	$7.90M
Williams & novak	99.21K	0.20%	$209.33K
Bard associates	267.70K	0.19%	$564.85K
Harvey partners	2.19M	0.14%	$1.24M
Heartland advisors	1.20M	0.14%	$2.53M
Pasadena private wealth	198.04K	0.09%	$417.86K
Greenwood capital associates	216.30K	0.06%	$456.39K

Top Buyers

Holder	Shares	% Assets	Change
Royce & associates lp	1.97M	0.04%	513.66K
Acadian asset management	998.79K	0.01%	125.18K
Amh equity	2.50M	5.19%	111.13K
Williams & novak	99.21K	0.20%	99.21K
Gamco investors, inc. et al	95.00K	0.00%	95.00K

Top Sellers

Holder	Shares	% Assets	Change
B. riley asset management	-	-	-1.35M
Boothbay fund management	-	-	-1.15M
Harvey partners	2.19M	0.14%	-495.50K
Russell investments group	2.92K	-	-298.30K
Archon capital management	-	-	-260.86K

New Positions

Holder	Shares	% Assets	Change	Value
Williams & novak	99.21K	0.20%	99.21K	$209.33K
Susquehanna group, llp	35.46K	-	35.46K	$74.81K
Virtu financial	35.39K	0.01%	35.39K	$101.00K
Sei investments	22.27K	0.00%	22.27K	$46.98K
Cubist systematic strategies	14.14K	0.00%	14.14K	$40.31K

Sold Out

Holder	Change
Capital performance advisors llp	-41.00
Qube research	-56.00
Ronald blue trust	-78.00
Smartleaf asset management	-174.00
Massmutual trust co fsb/adv	-271.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2025	2	-97.89%	3,715,394	-87.95%	8	0.17%	-	-100.00%	2	-91.67%
Dec 31, 2024	45	-52.63%	15,332,661	-50.99%	35	0.68%	26	-42.22%	8	-70.37%
Sep 30, 2024	95	-5.94%	30,343,546	-4.61%	69	1.30%	45	-26.23%	28	7.69%
Jun 30, 2024	101	12.22%	31,809,122	-2.15%	73	1.31%	61	79.41%	26	-35.00%
Mar 31, 2024	90	-4.26%	32,508,345	-1.43%	74	1.24%	34	-12.82%	40	37.93%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Harvey Partners Small-Cap Opportunity	2.02M	4.58%	-210.94K
Vanguard US Total Market Shares ETF	1.26M	2.86%	-
Vanguard Total Stock Mkt Idx Inv	1.26M	2.85%	-
Heartland Value Investor	937.14K	2.12%	-171.43K
iShares Russell 2000 ETF	905.30K	2.05%	153.00
Royce Micro-Cap Trust Inc	860.63K	1.95%	-11.42K
Royce Micro Cap Trust	860.63K	1.95%	-11.42K
Acuitas US Microcap Strategy	682.85K	1.57%	-
Royce Micro-Cap Invmt	638.54K	1.44%	-8.48K
Vanguard Institutional Extnd Mkt Idx Tr	579.99K	1.31%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 13, 2024	Green James W	Chief Executive Officer	Buy	$29.10K
Jun 06, 2024	Green James W	Chief Executive Officer	Buy	$61.40K
Aug 17, 2023	Green James W	Chief Executive Officer	Buy	$109.50K
Mar 14, 2023	EDRICK ALAN I	-	Buy	$36.87K
Mar 15, 2023	EDRICK ALAN I	-	Buy	$42.42K

Insider Transactions Trends

Date	Buy	Sell
2025 Q2	-	-
2025 Q1	-	-
2024 Q4	-	-
2024 Q2	2	-
2024 Q1	-	-

HBIO Ownership FAQ

Who Owns Harvard Bioscience?

Harvard Bioscience shareholders are primarily institutional investors at 8.43%, followed by 8.27% insiders and 83.30% retail investors. The average institutional ownership in Harvard Bioscience's industry, Medical Instruments & Supplies Stocks, is 44.25%, which Harvard Bioscience falls below.

Who owns the most shares of Harvard Bioscience?

Harvard Bioscience’s largest shareholders are Blackrock funding, inc. /de (2.98M shares, 6.84%), Blackrock (2.84M shares, 6.55%), and Punch & associates investment management (2.77M shares, 6.39%). Together, they hold 19.78% of Harvard Bioscience’s total shares outstanding.

Does Blackrock own Harvard Bioscience?

Yes, BlackRock owns 6.55% of Harvard Bioscience, totaling 2.84M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 8.1M$. In the last quarter, BlackRock increased its holdings by 9.99K shares, a 0.35% change.

Who is Harvard Bioscience’s biggest shareholder by percentage of total assets invested?

Amh equity is Harvard Bioscience’s biggest shareholder by percentage of total assets invested, with 5.19% of its assets in 2.5M Harvard Bioscience shares, valued at 5.28M$.

Who is the top mutual fund holder of Harvard Bioscience shares?

Harvey Partners Small-Cap Opportunity is the top mutual fund holder of Harvard Bioscience shares, with 4.58% of its total shares outstanding invested in 2.02M Harvard Bioscience shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools